Back to Rankings

MGTX

MeiraGTxD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
MGTX vs peer average
43/100
MGTX vs. peer average (D vs. D)
Grade spread
B 3 · C 2 · D 3 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

EDIT is the first available peer comparator.

Editas Medicine — gene-editing developer; peer for pipeline binary risk and capital-market sensitivity.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerEDITEditas Medicine
MGTX
MeiraGTx
EDIT
Editas Medicine
Grade
D
B
Momentum
74
82
Value
41
41
Sentiment
19
61
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Constructive

Grade position vs EDIT

MGTX / EDIT
Grade Position
Below peers
MGTX vs. peer average (D vs. D)
43/100
Momentum
74
EDIT
Value
41
MGTX
Sentiment
19
EDIT

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs MGTX
1
EDIT
EDIT
B
80/100
-2
2
RGNX
RGNX
F
20/100
+1
3
SRPT
SRPT
D
40/100
Even
4
ANNX
Annexon Inc Common
C
60/100
-1
5
ABUS
Arbutus Biopharma Corp Common
B
80/100
-2
EDIT is the first peer returned for this comparison set.